Submitted by Anonymous (not verified) on 3 July 2026 - 9:08
Opinion/decision on a Paediatric investigation plan (PIP): Idefirix, imlifidase, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Renal and urinary disorders, PIP number: EMEA-002183-PIP03-23
Source:
